We are joined by Dr Halis Akturk at the ADA annual meeting to discuss the topic of his two presentations, the advantages and limitations of closed-loop systems in patients with type 1 diabetes.
Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA
Questions:
1. Could you tell us a little about hybrid closed-loop systems and their advantages? (0:05)
2. What were the findings of your study of hybrid closed-loop system in patients with type 1 diabetes? (0:33)
3. What are the current limitations of this system and how may they be overcome? (1:52)
4. What have we learned about the association between immune checkpoint inhibitors and type 1 diabetes? (2:49)
5. Which patients are at highest risk of checkpoint-inhibitor induced diabetes? (4:37)
Halis Akturk has no conflicts of interest to declare in relation to this video.
touchENDO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
